Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.72 |
| ▸ | CCR5 | P51681 | 3/20 | 0.72 |
| ▸ | CCR8 | P51685 | 3/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.67 |
| ▸ | TP53 | P04637 | 4/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | ALPL | P05186 | 1/20 | 0.67 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.67 |
| ▸ | ALPI | P09923 | 1/20 | 0.67 |
| ▸ | ALPG | P10696 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | METAP1 | P53582 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL913279 | 0.92 | CCR1 (0.70) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL29577140 | 0.92 | CCR1 (0.70) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL8526623 | 0.92 | CCR1 (0.62) | CCR1CCR5CCR8KDM4ETP53 | |
| 2-Mercaptopyrimidine SCHEMBL7794551 | 0.91 | CCR1 (0.60) | CCR1CCR5CCR8KDM4ETP53 | |
| 4-Mercaptopyridine SCHEMBL7790757 | 0.87 | CCR1 (0.55) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL517337 | 0.84 | CCR1 (1.00) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL1617719 | 0.82 | CCR1 (0.96) | CCR1CCR5CCR8KDM4ETP53 | |
| SCHEMBL7964803 | 0.82 | KDM4E (1.00) | CCR1CCR5CCR8KDM4ETP53 | |
| Terpyridine SCHEMBL29357603 | 0.82 | KDM4E (1.00) | CCR1CCR5CCR8KDM4ETP53 | |
| Terpyridine SCHEMBL57442 | 0.82 | KDM4E (1.00) | CCR1CCR5CCR8KDM4ETP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024081853-A2 | MONOAMINE OXIDASE (MAO) ELECTROCHEMICAL BIOSENSOR AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2024-04-18 | — | — | WO | disclosed |
| US-10724903-B2 | Polymer encapsulated particles as surface enhanced Raman scattering probes | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-07-28 | — | — | US | disclosed |
| EP-3240833-B1 | LUMINESCENT SILICONE COATINGS | MOMENTIVE PERFORMANCE MAT INC (US) | 2020-06-03 | — | — | EP | disclosed |
| US-10294332-B2 | Functionalized siloxane materials | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2019-05-21 | — | — | US | disclosed |
| US-20180016401-A1 | FUNCTIONALIZED SILOXANE MATERIALS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2018-01-18 | — | — | US | disclosed |
| US-20170369715-A1 | LUMINESCENT SILICONE COATINGS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2017-12-28 | — | — | US | disclosed |
| EP-3240807-A1 | FUNCTIONALIZED SILOXANE MATERIALS | Momentive Performance Materials Inc. (US) | 2017-11-08 | — | — | EP | disclosed |
| EP-3240833-A1 | LUMINESCENT SILICONE COATINGS | Momentive Performance Materials Inc. (US) | 2017-11-08 | — | — | EP | disclosed |
| WO-2016144016-A1 | METHOD FOR PREPARING BIOSUGAR AND QUERCETIN BY USING ONION SKINS | 전남대학교산학협력단 | 2016-09-15 | — | — | WO | disclosed |
| WO-2016109537-A1 | FUNCTIONALIZED SILOXANE MATERIALS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2016-07-07 | — | — | WO | disclosed |
| US-20090106915-A1 | Coloring keratin fibers with metal complexes | CIBA SPECIALTY CHEMICALS CORP. | 2009-04-30 | — | — | US | disclosed |
| EP-1879548-A2 | PROCESS FOR COLORING KERATIN FIBERS COMPRISING METAL COMPLEXES | Ciba Specialty Chemicals Holding Inc. (CH) | 2008-01-23 | — | — | EP | disclosed |
| WO-2006120133-A2 | PROCESS FOR COLORING KERATIN FIBERS COMPRISING METAL COMPLEXES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-11-16 | — | — | WO | disclosed |
| US-20060019853-A1 | Use of metal complex compounds as catalysts for oxidation using molecular oxygen or air | CIBA SPECIALTY CHEMICALS CORP. | 2006-01-26 | — | — | US | disclosed |
| EP-1556468-A1 | USE OF METAL COMPLEX COMPOUNDS AS CATALYSTS FOR OXIDATION USING MOLECULAR OXYGEN OR AIR | Ciba SC Holding AG (CH) | 2005-07-27 | — | — | EP | disclosed |
| WO-2004039933-A1 | USE OF METAL COMPLEX COMPOUNDS AS CATALYSTS FOR OXIDATION USING MOLECULAR OXYGEN OR AIR | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-05-13 | — | — | WO | disclosed |
| EP-1144423-A1 | BIS-TERPYRIDINE-PLATINUM(II) COMPLEXES | ISIS INNOVATION LIMITED (GB) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000043405-A1 | BIS-TERPYRIDINE-PLATINUM(II) COMPLEXES | ISIS INNOVATION LIMITED (GB) | 2000-07-27 | — | — | WO | disclosed |
| EP-0885233-A1 | TERPYRIDINE-PLATINUM(II) COMPLEXES | ISIS INNOVATION LIMITED (GB) | 1998-12-23 | — | — | EP | disclosed |
| WO-1997027202-A1 | TERPYRIDINE-PLATINUM(II) COMPLEXES | ISIS INNOVATION LIMITED (GB) | 1997-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090106915-A1 | Coloring keratin fibers with metal complexes | KRT18, KIF5B, KIF5C | CCR1 2638/4885CCR5 2154/4885CCR8 2866/4885 |
| US-20060019853-A1 | Use of metal complex compounds as catalysts for oxidation using molecular oxygen or air | COX14, MICOS13, OR10J3 | CCR1 1334/4885CCR5 858/4885CCR8 883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.